Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FZL17
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,546
Award facts
- Contract value 100% obligated
- $42,546.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,546.46 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) under a firm fixed-price contract type. This delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a time-sensitive pharmaceutical procurement with no set-aside designation applied. The products will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters and distribution operations.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, leverages its existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through the SPE2DB program to fulfill this delivery order. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This particular delivery order for Xtandi—an oncology medication—reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, supporting Department of Defense healthcare requirements across military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FZL17?
SPE2DB25FZL17 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FZL17 worth?
The government has obligated $42,546 on SPE2DB25FZL17.
Is contract SPE2DB25FZL17 an order under another contract?
Yes. SPE2DB25FZL17 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL17 competed?
The extent of competition for SPE2DB25FZL17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award